DRAGO, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 20.146
NA - Nord America 18.335
AS - Asia 17.404
SA - Sud America 1.989
AF - Africa 352
OC - Oceania 169
Continente sconosciuto - Info sul continente non disponibili 29
Totale 58.424
Nazione #
US - Stati Uniti d'America 17.555
IT - Italia 6.192
SG - Singapore 5.437
GB - Regno Unito 5.407
CN - Cina 5.271
RU - Federazione Russa 1.545
DE - Germania 1.500
BR - Brasile 1.418
VN - Vietnam 1.414
HK - Hong Kong 1.309
SE - Svezia 1.253
FR - Francia 937
IN - India 800
BD - Bangladesh 756
NL - Olanda 554
UA - Ucraina 516
IE - Irlanda 504
TR - Turchia 504
KR - Corea 492
CA - Canada 441
FI - Finlandia 382
ID - Indonesia 358
PL - Polonia 246
ES - Italia 242
DK - Danimarca 215
JP - Giappone 215
EU - Europa 201
MX - Messico 200
CO - Colombia 168
AU - Australia 146
TW - Taiwan 124
AR - Argentina 116
BE - Belgio 96
EC - Ecuador 85
PH - Filippine 84
CI - Costa d'Avorio 83
IQ - Iraq 77
RO - Romania 72
IR - Iran 71
AT - Austria 64
CH - Svizzera 64
GR - Grecia 64
PK - Pakistan 59
ZA - Sudafrica 56
TH - Thailandia 54
UZ - Uzbekistan 54
EG - Egitto 51
PE - Perù 50
CL - Cile 45
MY - Malesia 44
CZ - Repubblica Ceca 43
SA - Arabia Saudita 42
VE - Venezuela 39
PT - Portogallo 37
AE - Emirati Arabi Uniti 32
PY - Paraguay 31
MA - Marocco 30
IL - Israele 25
NO - Norvegia 24
AZ - Azerbaigian 23
NZ - Nuova Zelanda 23
KE - Kenya 22
KZ - Kazakistan 20
RS - Serbia 20
UY - Uruguay 20
HU - Ungheria 19
JO - Giordania 19
AL - Albania 18
JM - Giamaica 18
NG - Nigeria 18
NP - Nepal 18
DO - Repubblica Dominicana 17
DZ - Algeria 17
HN - Honduras 17
SK - Slovacchia (Repubblica Slovacca) 17
BO - Bolivia 16
CR - Costa Rica 15
ET - Etiopia 15
PA - Panama 15
GE - Georgia 14
LT - Lituania 14
IS - Islanda 13
LB - Libano 13
LV - Lettonia 13
BG - Bulgaria 12
MD - Moldavia 12
TN - Tunisia 12
HR - Croazia 10
KH - Cambogia 10
LU - Lussemburgo 10
NI - Nicaragua 9
BY - Bielorussia 8
GT - Guatemala 8
AO - Angola 7
MN - Mongolia 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CY - Cipro 6
KW - Kuwait 6
OM - Oman 6
Totale 58.464
Città #
Southend 4.579
Singapore 3.262
Ashburn 1.670
Milan 1.212
Hong Kong 1.177
San Jose 1.160
Seattle 1.004
Chandler 953
Beijing 915
Fairfield 901
Wilmington 717
Dallas 691
Council Bluffs 657
Princeton 587
Dublin 490
Ann Arbor 489
Woodbridge 474
Santa Clara 427
Houston 409
Ho Chi Minh City 407
Los Angeles 397
Jacksonville 356
Hanoi 349
Mountain View 335
Bengaluru 308
Guangzhou 298
Nanjing 294
Rome 294
New York 276
Lauterbourg 270
Cambridge 266
Dearborn 264
Redmond 249
Moscow 235
Toronto 233
Des Moines 225
Hefei 219
Boardman 217
Jakarta 214
Shanghai 211
Frankfurt am Main 207
Brooklyn 205
Buffalo 201
Redwood City 158
The Dalles 157
São Paulo 139
Jinan 137
Columbus 135
Tokyo 132
Sakarya 130
Tianjin 127
Helsinki 126
Shenyang 125
Serra 124
Bogotá 113
Warsaw 113
Seoul 104
Munich 101
Andover 100
Phoenix 99
Naples 98
Istanbul 96
Hangzhou 95
Changsha 91
Cangzhou 83
Abidjan 82
London 80
Berlin 76
Nanchang 76
Bologna 75
Hanover 75
Shenzhen 70
San Diego 68
Hebei 63
Turin 60
Taipei 58
Chicago 57
Da Nang 57
Mumbai 56
Montreal 54
Zhengzhou 54
Palermo 53
Brussels 52
Washington 52
Madrid 51
Wuhan 51
Nuremberg 49
Atlanta 48
Bari 48
Haiphong 48
Athens 47
Orem 46
Verona 46
Florence 44
Paris 44
Eitensheim 43
Somerville 43
Sydney 42
Catania 41
Pisa 41
Totale 32.837
Nome #
Probiotics in the prevention and treatment of atopic dermatitis 1.978
Colonizzazione intestinale di Lactobacillus casei subsp. casei I-1572 CNCM (L.casei DG) in volontari sani e in topi germ-free 1.855
Resistenza di Pseudomonas aeruginosa a ciprofloxacina e levofloxacina : 1998-2002 1.398
Lactobacillus sporogenes or Bacillus coagulans: misidentification or Mislabelling? 704
Activity of levoflaxin and ciprofloxacin against urinary pathogens 482
Modulation of opportunistic species Corynebacterium diphtheriae, Haemophilus parainfluenzae, Moraxella catarrhalis, Prevotella denticola, Prevotella melaninogenica, Rothia dentocariosa, Staphylococcus aureus and Streptococcus pseudopneumoniae by intranasal administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a combination in healthy subjects 449
Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract 442
Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier 417
The World Association against Infection in Orthopaedics and Trauma (WAIOT) procedures for Microbiological Sampling and Processing for Periprosthetic Joint Infections (PJIs) and other Implant-Related Infections 365
Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals 362
Serum and lung levels of thiamphenicol after administration of its glycinate N-acetylcysteinater ester in experimentally infected guinea pigs 346
Attività antimicrobica della propoli: cosa c'è di nuovo? 341
null 338
Deep transcranial magnetic stimulation affects gut microbiota composition in obesity : results of randomized clinical trial 333
Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation 332
Probiotics in the add-on treatment of otitis media in clinical practice 329
Antibacterial coating of implants in orthopaedics and trauma : a classification proposal in an evolving panorama 324
Topical administration of hyaluronic acid in children with recurrent or chronic middle ear inflammations 320
Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin 319
Antibiotic sensitivities of coagulase-negative staphylococci and Staphylococcus aureus in hip and knee periprosthetic joint infections : does this differ if patients meet the International Consensus Meeting Criteria? 316
Complicanze nell’elevazione del seno mascellare: Consensus interdisciplinare diagnostico/terapeutico e raccomandazioni cliniche per ridurre l’incidenza=Complications associated with maxillary sinus lift: iagnostic/Therapeutic Interdisciplinary Consensus and clinical recommendations in reducing the incidence 304
Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections? 304
In vitro comparison between α-tocopheryl acetate and α-tocopheryl phosphate against bacteria responsible of prosthetic and joint infections 300
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections 299
A probiotic mixture in patients with upper respiratory diseases: the point of view of the otorhinolaringologist 299
Probiotics reduce gut microbial translocation and improve adult atopic dermatitis 290
Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers 290
Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against defferent P. aeruginosa phenotype and Acinetobacter spp. 283
In vitro antiviral activity of resveratrol against respiratory viruses 280
How to Study Biofilms after Microbial Colonization of Materials Used in Orthopaedic Implants 270
Microbiota network and mathematic microbe mutualism in colostrum and mature milk collected in two different geographic areas: Italy versus Burundi 269
Prevention and treatment of postoperative infections after sinus elevation surgery: clinical consensus and recommendations 266
Modeling Staphylococcus epidermidis-Induced Non-Unions : Subclinical and Clinical Evidence in Rats 265
Comparative evaluation of synergy of combinations of β-lactams with fluoroquinolones or macrolides in Streptococcus pneumoniae 264
Putative Microbial Population Shifts Attributable to Nasal Administration of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a 264
What Pediatricians Should Know Before Studying Gut Microbiota 263
Fast-resorbable antibiotic-loaded hydrogel coating to reduce post-surgical infection after internal osteosynthesis : a multicenter randomized controlled trial 261
High SPARC expression starting from dysplasia, associated with breast carcinoma, is predictive for bone metastasis without enhancement of plasma levels 260
Systemic and Local Administration of Antimicrobial and Cell Therapies to Prevent Methicillin-Resistant Staphylococcus epidermidis-Induced Femoral Nonunions in a Rat Model 258
Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review 256
Upper Respiratory Tract Microbiome and Otitis Media Intertalk : Lessons from the Literature 256
Recent evidence on bioactive glass antimicrobial and antibiofilm activity : a mini-review 255
Bioactive glass bag-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: An in vitro and prospective clinical study 251
New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome : a pilot study 250
Alpha defensin, leukocyte esterase, C-reactive protein, and leukocyte count in synovial fluid for pre-operative diagnosis of periprosthetic infection 249
Two-stage revision surgery with preformed spacers and cementless implants for septic hip arthritis : a prospective, non-randomized cohort study 247
Inflammatory bowel diseases, the hygiene hypothesis and the other side of the microbiota: Parasites and fungi 246
"Combined Diagnostic Tool" APPlication to a Retrospective Series of Patients Undergoing Total Joint Revision Surgery 245
Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies 244
Antibiofilm activity of sandblasted and laser-modified titanium against microorganisms isolated from peri-implantitis lesions 243
Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease : which strains act as health players? 243
A comparative in vitro evaluation of resistance development after exposure to teicoplanin, vancomycin, linezolid and quinupristin/dalfopristin in Staphylococcus spp. and Enterococcus spp. 242
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations 242
Antibiofilm agents against MDR bacterial strains : is bioactive glass BAG-S53P4 also effective? 242
Draft genome sequence of Staphylococcus epidermidis clinical strain GOI1153754-03-14 isolated from an infected knee prosthesis 242
Impact of delivery mode on the colostrum microbiota composition 241
Activity of a lactobacillus acidophilus-based douche for the treatment of bacterial vaginosis 238
Circulating sRAGE in the diagnosis of osteolytic bone metastasis 236
Role of Biofilms in Children with Chronic Adenoiditis and Middle Ear Disease 236
Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536 235
Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma : an in vitro study 234
In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections : Comparative Evaluation with Gentamicin and Fusidic Acid 233
Comparison of nested PCR and real time PCR of Herpesvirus infections of central nervous system in HIV patients 232
Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity 227
Dati preliminari sull'accuratezza diagnostica del tampone rinofaringeo nell'identificazione del biofilm in pazienti pediatrici con adenoidite cronica 226
Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media 226
Role of the Human Breast Milk-Associated Microbiota on the Newborns' Immune System : a Mini Review 226
Use of genomics and proteomics to develop better diagnostic tools for use in infectious diseases 224
Does PGE1 vasodilator prevent orthopaedic implant-related infection in diabetes? Preliminary results in a mouse model 224
Plasmatic soluble receptor for advanced glycation end products (SRAGE) as a new oxidative stress biomarker in patients with prosthetic-joint-associated infections 223
The W.A.I.O.T. Definition of High-Grade and Low-Grade Peri-Prosthetic Joint Infection 222
Sinonasal-Related Orbital Infections in Children: A Clinical and Therapeutic Overview 221
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations 220
Erythritol/chlorhexidine combination reduces microbial biofilm and prevents its formation on titanium surfaces in vitro 220
Masquelet technique: myth or reality? : A systematic review and meta-analysis 220
A consumer's guide for probiotics : 10 golden rules for a correct use 220
Economic Evaluation of Antibacterial Coatings on Healthcare Costs in First Year Following Total Joint Arthroplasty 220
Healing of surgical site after total hip and knee replacements show similar telethermographic patterns 217
Plasma endocannabinoid behaviour in total knee and hip arthroplasty 217
Epidemiology and Antibiotic Resistance of Late Prosthetic Knee and Hip Infections 216
Should Lactobacillus sporogenes and Bacillus coagulans have a future ? 214
Predicting lower limb periprosthetic joint infections : a review of risk factors and their classification 214
Sinergia tra glicopeptidi, levofloxacina e beta-lattamici nei confronti di Staphylococcus aureus resistenti alla meticillina 212
The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706) 210
Valutazione microbiologica di prodotti probiotici presenti in commercio 210
Improving the bacterial recovery by using dithiothreitol with aerobic and anaerobic broth in biofilm-related prosthetic and joint infections 210
Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria responsible for respiratory tract infections 209
Antibacterial coating of implants : are we missing something? 209
Attività antimicrobica di ibuprofene isobutanolammonio nei confronti di germi isolati da campioni vaginali 208
BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria 208
Cultivable and pyrosequenced fecal microflora in centenarians and young subjects 207
Toll-like receptor 2 in serum: a potential diagnostic marker of prosthetic joint infection? 207
In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates 205
Effect of Limosilactobacillus reuteri LRE02-Lacticaseibacillus rhamnosus LR04 combination on antibiotic-associated diarrhea in a pediatric population : a national survey 204
Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes 202
Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones 201
Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides 200
Prolonging culture to 15 days improves bacterial detection in bone and joint infections 200
Comparative evaluation of MicroDTTect device and flocked swabs in the diagnosis of prosthetic and orthopaedic infections 200
Antimicrobial activity of thyamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae 199
Totale 30.775
Categoria #
all - tutte 149.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 0 0 310
2021/20223.509 298 139 159 214 292 250 245 193 406 339 291 683
2022/20234.373 513 368 373 445 496 861 142 260 429 103 247 136
2023/20243.423 126 337 220 214 660 219 178 259 100 231 386 493
2024/20258.333 424 803 332 663 641 420 429 908 535 631 741 1.806
2025/202617.396 1.536 1.138 2.076 1.290 1.655 1.213 2.031 1.180 1.918 1.162 1.802 395
Totale 61.231